The new insight into the inflammatory response following focused ultrasound-mediated blood-brain barrier disruption.
Authors: Choi HJ, Han M, Seo H, Park CY, Lee EH, Park J
Despite the great potential of FUS-BBB disruption (FUS-BBBD), it is still controversial whether FUS-BBBD acts as an inducing factor of neuro-inflammation or not, and the biological responses after FUS-BBBD triggers the inflammatory process are poorly understood. The aim of this study is to investigate the safety window for FUS levels based on a comprehensive safety assessment. The mice were treated with two different ultrasound parameters (0.25 MPa and 0.42 MPa) in the thalamus region of brain. The efficacy of BBB opening was verified by dynamic contrast-enhanced MRI (DCE-MRI) and the cavitation monitoring. The transcriptome analysis was performed to investigate the molecular response for the two BBBD conditions after FUS-mediated BBB opening in time-dependent manners. Histological analysis was used for evaluation of the tissue damage, neuronal degeneration, and activation of glial cells induced by FUS-BBBD. The BBBD, as quantified by the K<sub>trans</sub>, was approximately threefold higher in 0.42 MPa-treated group than 0.25 MPa-treated group. While the minimal tissue/cellular damage was found in 0.25 MPa-treated group, visible damages containing microhemorrhages and degenerating neurons were detected in 0.42 MPa-treated group in accordance with the extent of BBBD. In transcriptome analysis, 0.42 MPa-treated group exhibited highly dynamic changes in the expression levels of an inflammatory response or NF-κB pathway-relative genes in a time-dependent manner whereas, 0.25 MPa was not altered. Interestingly, although it is clear that 0.42 MPa induces neuroinflammation through glial activation, neuroprotective properties were evident by the expression of A2-type astrocytes. Our findings propose that a well-defined BBBD parameter of 0.25 MPa could ensure the safety without cellular/tissue damage or sterile inflammatory response in the brain. Furthermore, the fact that the excessive sonication parameters at 0.42 MPa could induce a sterile inflammation response via glial activation suggested the possibility that could lead to tissue repair toward the homeostasis of the brain microenvironment through A2-type reactive astrocytes.
Introduction
Purpose
Drug delivery with BBB opening
Study Objective
To determine the safety window for focused ultrasound–mediated blood–brain barrier disruption by comprehensively comparing imaging, cavitation, histological, and transcriptomic responses at two ultrasound pressures (0.25 MPa vs 0.42 MPa).
Animal model / Human subject
Mouse (mice); strain: not specified; age: not specified; sex: not specified
Targeted brain region(s)
Thalamus
Outcomes and Safety
Summary of Outcomes
FUS-BBBD at 0.25 MPa produced safe, efficacious BBB opening without cellular/tissue damage or sterile inflammation (successful), whereas 0.42 MPa generated ~3-fold greater BBB permeability but caused microhemorrhages, neuronal degeneration and NF-κB–mediated neuroinflammation with microglial and astrocyte activation (predominantly A2-type astrocytes).
Duration of biological effect
48 h
Safety-related matter
A 0.25 MPa FUS-BBBD condition opened the BBB without cellular/tissue damage, neurodegeneration, or sterile inflammatory responses, indicating a safe parameter; by contrast, 0.42 MPa produced visible tissue injury (microhemorrhages, microvacuolation, degenerating neurons), induced NF-κB–associated sterile neuroinflammation and glial activation (microglia/astrocytes), and was linked to inertial/ultra-harmonic cavitation indicative of adverse effects.
Brain Region
Ultrasound Parameters
Ultrasound instrument
not reported
FUS Frequency
not reported
FUS Intensity
not reported
FUS Pressure
0.25 MPa, 0.42 MPa
FUS Mode
not reported
Pulse duration
not reported
Duration of a single FUS session
not reported
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search